BofA/Merrill Lynch Upgrades Integra LifeSciences (IART) to Buy
Get Alerts IART Hot Sheet
Price: $34.83 +3.20%
Rating Summary:
10 Buy, 13 Hold, 3 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 6 | Down: 3 | New: 1
Rating Summary:
10 Buy, 13 Hold, 3 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 6 | Down: 3 | New: 1
Join SI Premium – FREE
BofA/Merrill Lynch upgraded Integra LifeSciences (NASDAQ: IART) from Neutral to Buy with a price target of $79.00.
For an analyst ratings summary and ratings history on Integra LifeSciences click here. For more ratings news on Integra LifeSciences click here.
Shares of Integra LifeSciences closed at $64.23 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Integra Lifesciences Holdings Corp - IART
- HSBC Upgrades SGL Carbon SE (SGL:GR) (SGLFF) to Buy, 'expectations have been sufficiently reset'
- Raymond James Upgrades Public Storage (PSA) to Strong Buy
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!